Xuzhou, China

Zhenyun Peng

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nhwa Pharma. Corporation. Active years: 2010.


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhenyun Peng: Innovator in Pharmaceutical Processes

Introduction

Zhenyun Peng is a notable inventor based in Xuzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of gabapentin hydrochloride. His innovative approach has the potential to enhance production efficiency and product quality.

Latest Patents

Zhenyun Peng holds a patent for a process titled "Process for the preparation of gabapentin hydrochloride." This process involves converting 1,5-dicyano-2,4-dioxo-3-azaspiro[5,5]-undecane into 1,5-diaminoformyl-2,4-dioxo-3-azaspiro[5,5]-undecane at a temperature of 65°C to 85°C in the presence of a strong acid. Following this, a Hofmann rearrangement is carried out under alkaline conditions. The starting material for this process is readily available, making it a practical solution. The method is designed to simplify the purification procedure of intermediates, reduce production costs, and yield a product with higher purity. Zhenyun Peng has 1 patent to his name.

Career Highlights

Zhenyun Peng is currently associated with Nhwa Pharmaceutical Corporation, where he applies his expertise in pharmaceutical processes. His work focuses on developing efficient methods for drug preparation, contributing to advancements in the industry.

Collaborations

Zhenyun collaborates with Wei Zhu, a fellow professional in the pharmaceutical field. Their partnership aims to enhance research and development efforts within their organization.

Conclusion

Zhenyun Peng's innovative contributions to pharmaceutical processes exemplify the impact of effective invention in the industry. His work not only improves production efficiency but also ensures higher quality products.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…